Chicago, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Citizens United for Research in Epilepsy, founded in 1998, is a community nonprofit in the Medical Research sector that reported $5.0M in total revenue in fiscal year 2025. Revenue decreased 18% compared to the prior year. Expenses of $5.5M exceeded revenue, resulting in a 11% operating deficit.
To find a cure for epilepsy by promoting and funding patient focused research.
Since its inception in 1998, CURE Epilepsy has raised more than 100 million to fund epilepsy research and other initiatives that will lead the way to cures for the epilepsies. CURE Epilepsy awards...
Since its inception in 1998, CURE Epilepsy has raised more than 100 million to fund epilepsy research and other initiatives that will lead the way to cures for the epilepsies. CURE Epilepsy awards grants for novel research projects to prevent epilepsy related to pediatric epilepsy, post-traumatic epilepsy, treatment resistant epilepsies, sudden unexplained death in epilepsy SUDEP, and sleep and epilepsy advancing the search for a cure, eliminating treatment side effects, and reversing deficits caused by frequent seizures, CURE Epilepsy funds grants for young and established investigators and to date has awarded more than 300 grants in 19 countries around the world.
CURE Epilepsy believes that awareness is a critical vehicle to increase the amount of funding for epilepsy research and to share key learnings and opportunities for those impacted by epilepsy. CURE...
CURE Epilepsy believes that awareness is a critical vehicle to increase the amount of funding for epilepsy research and to share key learnings and opportunities for those impacted by epilepsy. CURE Epilepsy creates, sponsors and levers our website, webinars, seminars, podcasts, educational events and other digital communication to drive this critical awareness.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $4,989,172 | $6,050,647 | -0.2% |
| Expenses | $5,529,185 | $6,196,609 | -0.1% |
| Net Income | $-540,013 | $-145,962 | +2.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Beth Dean | CEO | 037.50 |
Officer
Highest
|
$344,007 | $0 | $344,007 |
| Laura Lubbers | CSO | 037.50 |
Officer
Highest
|
$343,883 | $0 | $343,883 |
| Alysha Biehl | Director of Development | 037.50 |
Highest
|
$170,346 | $0 | $170,346 |
| Dana Vielmetti | Director of Marketing and Communications | 037.50 |
Highest
|
$164,251 | $0 | $164,251 |
| Priya Balasurbramanian | Director of Research | 037.50 |
Highest
|
$138,007 | $0 | $138,007 |
| Elaine O'Loughlin | Associate Director of Research Initiatives | 037.50 |
Highest
|
$134,338 | $0 | $134,338 |
| John Anderluh | CFO | 030.00 |
Officer
|
$106,400 | $0 | $106,400 |
| Angela Mota | Director of Major Gifts | 037.50 |
Highest
|
$100,904 | $0 | $100,904 |
| Lisa Cotton | Immediate Past Chair | 004.00 |
Director
|
$0 | $0 | $0 |
| Shalee Cunneen | Secretary | 004.00 |
Officer
Director
|
$0 | $0 | $0 |
| Steve Austin | Director | 002.00 |
Director
|
$0 | $0 | $0 |
| Irina Colon | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Kim Borden | Director | 002.00 |
Director
|
$0 | $0 | $0 |
| Roger Heldman | Treasurer | 004.00 |
Officer
Director
|
$0 | $0 | $0 |
| Carrie Garman | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Maureen Flood Rabus | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| David Reifman | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Walter Kelly | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Matt Schneider | Director | 004.00 |
Director
|
$0 | $0 | $0 |
| Kelly Cervantes | Director | 004.00 |
Director
|
$0 | $0 | $0 |
| Michael Alexrod | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Greg Mayes | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Jonathan Tuteur | Director | 004.00 |
Director
|
$0 | $0 | $0 |
| Justin Gover | Chair | 006.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,989,172 | $5,529,185 | $10,409,120 | $-540,013 |
| 2024 | $6,050,647 | $6,196,609 | $10,689,964 | $-145,962 |
| 2023 | $6,183,163 | $5,993,350 | $10,587,072 | $189,813 |
| 2022 | $6,231,376 | $5,793,113 | $10,154,743 | $438,263 |
| 2021 | $6,043,691 | $5,841,537 | $10,496,452 | $202,154 |
| 2020 | $7,343,836 | $7,549,802 | $10,595,195 | $-205,966 |
| 2019 | $7,484,913 | $6,263,446 | $11,158,995 | $1,221,467 |
| 2018 | $7,450,862 | $5,969,013 | $6,395,235 | $1,481,849 |
Compare Citizens United for Research in Epilepsy with other nonprofits in Illinois and across the country.